Molecular Templates Inc (NASDAQ:MTEM) does about 4.00M shares in volume on a normal day but saw 7608839 shares change hands in the recent trading day. The company now has a market cap of 4.94M USD. Its current market price is $0.75, marking a decrease of -19.35% compared to the previous close of $0.93. The 52 week high reached by this stock is $6.49 whilst the lowest price level in 52 weeks is $0.29.
Molecular Templates Inc (MTEM) has a 20-day trading average at $1.1820 and the current price is -88.44% off the 52-week high compared with 154.24% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.3239 and its 200-day simple moving average is $1.9804. If we look at the stock’s price movements over the week, volatility stands at 65.49%, which decreases to 20.28% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 39.69 to suggest the stock is neutral.
The consensus objective for the share price is $18.00, suggesting that the stock has a potential upside of 95.83% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 21, 2021 when BofA Securities initiated the stock to “Buy” and issued a price target of $12. Jefferies initiated its price target at $21.
The current price level is -36.55%, -43.35%, and -62.13% away from its SMA20, SMA50, and SMA200 respectively, with the MTEM price moving above the 50-day SMA on current market day. Molecular Templates Inc (MTEM) stock is down -48.98% over the week and -44.85% over the past month. Its price is -79.89% year-to-date and -87.98% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/30/2024, with the company’s earnings per share (EPS) of -0.82 above consensus estimates by 0.57. The company’s next earnings report forecasts estimating quarterly EPS at -1.03 and -2.93 for whole year. Expected sales for next quarter are $340k, which analysts say will come at $12.33M for the current fiscal year and next year at $1.26M. In addition, estimates put the company’s current quarterly revenue at an average of $330k.
To reach the target analysts have set, the stock logically needs to grow 95.83 percent from here.
The company has a return on investment of -100.81% and return on equity of -929.14%. The beta has a value of 1.13. Price to book ratio is 0.69 and price to sales ratio is 0.19.
